Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
13.98
+0.73 (5.51%)
At close: May 3, 2024, 4:00 PM
14.31
+0.33 (2.36%)
After-hours: May 3, 2024, 7:40 PM EDT

Pliant Therapeutics Revenue

In the year 2023, Pliant Therapeutics had annual revenue of $1.58M, a decrease of -83.69%.

Revenue (ttm)
$1.58M
Revenue Growth
-83.69%
P/S Ratio
533.71
Revenue / Employee
$10,000
Employees
158
Market Cap
843.26M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.58M-8.11M-83.69%
Dec 31, 20229.69M2.11M27.91%
Dec 31, 20217.57M-34.25M-81.89%
Dec 31, 202041.82M-15.24M-26.70%
Dec 31, 201957.05M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 1.99B
Healthcare Services Group 1.68B
Paragon 28 216.39M
Evolus 202.09M
Cytek Biosciences 193.02M
OrthoPediatrics 148.73M
Sage Therapeutics 91.06M
REGENXBIO 90.24M
Revenue Rankings